Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department
Latest Information Update: 10 Feb 2025
At a glance
- Drugs V 503 (Primary)
- Indications Human papillomavirus infections
- Focus Therapeutic Use
Most Recent Events
- 07 Feb 2025 Planned End Date changed from 1 Jul 2025 to 1 Jun 2026.
- 07 Feb 2025 Planned primary completion date changed from 1 Feb 2025 to 1 Dec 2025.
- 12 Aug 2024 Status changed from not yet recruiting to recruiting.